Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.0 - $9.95 $0 - $69,669
7,002 Added 9.93%
77,551 $502,000
Q1 2022

May 16, 2022

BUY
$10.07 - $11.93 $63,491 - $75,218
6,305 Added 9.81%
70,549 $817,000
Q1 2022

May 13, 2022

SELL
$10.07 - $11.93 $63,491 - $75,218
-6,305 Reduced 8.94%
64,244 $681,000
Q4 2021

Feb 14, 2022

SELL
$7.95 - $11.24 $67,893 - $95,989
-8,540 Reduced 10.8%
70,549 $783,000
Q2 2021

Aug 13, 2021

BUY
$9.91 - $12.78 $147,113 - $189,719
14,845 Added 23.11%
79,089 $890,000
Q4 2020

Feb 12, 2021

SELL
$9.3 - $11.77 $24,180 - $30,602
-2,600 Reduced 3.89%
64,244 $697,000
Q3 2020

Nov 13, 2020

SELL
$7.59 - $10.8 $27,566 - $39,225
-3,632 Reduced 5.15%
66,844 $650,000
Q2 2020

Aug 14, 2020

SELL
$7.96 - $11.54 $35,613 - $51,629
-4,474 Reduced 5.97%
70,476 $561,000
Q1 2020

May 14, 2020

SELL
$7.69 - $11.68 $152,438 - $231,532
-19,823 Reduced 20.92%
74,950 $651,000
Q4 2019

Feb 14, 2020

BUY
$9.09 - $11.89 $29,697 - $38,844
3,267 Added 3.57%
94,773 $1.07 Million
Q3 2019

Nov 14, 2019

BUY
$9.66 - $12.36 $5,622 - $7,193
582 Added 0.64%
91,506 $995,000
Q2 2019

Aug 12, 2019

SELL
$9.32 - $12.98 $168,356 - $234,470
-18,064 Reduced 16.57%
90,924 $852,000
Q1 2019

May 15, 2019

SELL
$10.35 - $13.06 $7,245 - $9,142
-700 Reduced 0.64%
108,988 $1.34 Million
Q4 2018

Feb 15, 2019

BUY
$11.64 - $15.41 $17,401 - $23,037
1,495 Added 1.38%
109,688 $1.3 Million
Q3 2018

Nov 13, 2018

BUY
$12.65 - $15.15 $8,007 - $9,589
633 Added 0.59%
108,193 $1.56 Million
Q2 2018

Aug 10, 2018

BUY
$13.05 - $15.45 $7,503 - $8,883
575 Added 0.54%
107,560 $1.6 Million
Q1 2018

May 15, 2018

BUY
$12.0 - $14.45 $40,680 - $48,985
3,390 Added 3.27%
106,985 $1.4 Million
Q4 2017

Feb 14, 2018

BUY
$11.65 - $13.35 $223,412 - $256,012
19,177 Added 22.72%
103,595 $1.31 Million
Q3 2017

Nov 14, 2017

BUY
$11.95 - $13.35 $1.01 Million - $1.13 Million
84,418
84,418 $1.09 Million

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.